Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Good Society is a Berlin-based venture studio dedicated to building and scaling companies focused on longevity and human healthspan. Founded by serial entrepreneur Nils Regge, the firm identifies high-potential scientific breakthroughs and translates them into consumer-facing health products and biotechnology platforms. The studio's portfolio includes ventures specializing in preventative medicine, advanced diagnostics, and therapeutic interventions aimed at slowing the aging process. Good Society provides its incubated companies with operational support, strategic guidance, and initial capital to accelerate their path to market. Key portfolio companies include Centenarian, which focuses on longevity diagnostics, and Everest Health, a platform for personalized health optimization. By bridging the gap between deep science and market-ready solutions, Good Society aims to extend the period of life spent in good health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Good Society.